Wolfe Research upgrades CrowdStrike stock rating on valuation By Investing.com

Wolfe Research upgraded CrowdStrike to Outperform with a $450 price target (~22% upside) and calls the current valuation (~13x EV/CY27E revenue; ~40x EV/CY27E FCF) a relatively attractive entry despite recent weakness. Shares are down ~21% YTD, ~10.6% over the past week and ~23% over three months; LTM revenue grew 21.7% and gross margin is 74.8%. Wolfe argues the premium to peers (≈26% on revenue multiple, 50% on FCF multiple) is justified by accelerating growth and expanding margins; Citizens set a $550 target and Macquarie/Evercore highlight RSA-driven demand and AI-related risks. Near-term volatility is driven by Anthropic’s Claude Mythos release, while a strategic collaboration with Intel to optimize Falcon for AI PCs is a potential catalyst.

Analysis

AI-driven advances in offensive tooling are creating two simultaneous market forces: a near-term spike in headline-driven volatility and a multi-year secular increase in demand for higher-fidelity telemetry and automated detection. Vendors that control end-to-end telemetry pipelines and can operationalize ML models at scale will capture disproportionate economics as customers prioritize turnkey, low-friction upgrades over point-product stitching.

Silicon- and OS-level integrations are a non-obvious accelerator — they both raise the baseline quality of telemetry (helpful for defenders) and risk commoditizing low-value features, forcing vendors to sell higher up the stack (runtime prevention, threat intelligence, managed detection). Expect procurement cycles to lengthen as enterprises evaluate integration depth: news-driven re-rates can happen in days-weeks, but durable enterprise wins or losses play out over 3-12 months and meaningfully shift FCF conversion over 12-36 months.

The market is bifurcating between platform players with cloud-scale ML and pure-play vendors exposed to feature commoditization. Consensus underestimates the asymmetry: a single large OEM or OS integration win can expand TAM for a platform vendor by unlocking OEM-distributed endpoints, while the same dynamic can compress multiples for narrow-scope vendors. That creates a tactical window — buy optionality on platform leaders while hedging event risk tied to successive high-capability model releases.

Key Decisions for Investors

• Overweight the platform leader (CRWD) via a 12–24 month diagonal or call-spread (buy LEAP, sell higher strike) to capture re-rating if the company converts OEM/OS integrations into ARR; target 2–3x upside in successful-execution scenario, limit downside to premium paid.
• Pair trade: long CRWD / short ZS (equal dollar) over 6–12 months to express endpoint platform wins vs cloud-segmentation incumbents; expect 10–30% relative skew if endpoint integration momentum continues, cut if divergence persists for >12 months.
• Tactical hedge: buy 3-month ATM puts on CRWD sized to 20–30% of long exposure to protect against headline-driven model-release shocks and near-term multiple compression; treat as insurance against 1–2 quarter execution misses.
• Small thematic stake in silicon/OS players (INTC) for 6–12 months to play upstream telemetry adoption — keep position size ~1–2% of portfolio as optional upside, with stop-loss at 20–30% given macro sensitivity.